Guglielmelli, P., Barosi, G., Rambaldi, A., Marchioli, R., Masciulli, A., Tozzi, L., . . . Vannucchi, A. M. (2011). Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis. American Society of Hematology.
Citação norma ChicagoGuglielmelli, Paola, et al. Safety and Efficacy of Everolimus, a MTOR Inhibitor, As Single Agent in a Phase 1/2 Study in Patients With Myelofibrosis. American Society of Hematology, 2011.
MLA CitationGuglielmelli, Paola, et al. Safety and Efficacy of Everolimus, a MTOR Inhibitor, As Single Agent in a Phase 1/2 Study in Patients With Myelofibrosis. American Society of Hematology, 2011.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.